Home/Filings/4/0001193125-26-006328
4//SEC Filing

Patel Sanjiv 4

Accession 0001193125-26-006328

CIK 0001812364other

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 4:15 PM ET

Size

9.2 KB

Accession

0001193125-26-006328

Insider Transaction Report

Form 4
Period: 2026-01-06
Patel Sanjiv
DirectorPresident and CEO
Transactions
  • Award

    Common Stock

    2025-12-31$2.99/sh+994$2,972704,209 total
  • Sale

    Common Stock

    2026-01-06$7.82/sh43,168$337,574661,041 total
Holdings
  • Common Stock

    (indirect: By Trust)
    199,548
  • Common Stock

    (indirect: By Trust)
    687,355
Footnotes (6)
  • [F1]The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction.
  • [F2]In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on July 1, 2025.
  • [F3]Includes 136,854 shares underlying restricted stock units ("RSUs").
  • [F4]Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 136,854 shares of RSUs on January 5, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
  • [F5]These shares are held in irrevocable trusts for the benefit of the reporting person's family members. An independent trustee is trustee of the trusts. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  • [F6]These shares were held in irrevocable trusts for the benefit of the reporting person's family members. An independent trustee is trustee of the trusts. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Documents

1 file

Issuer

Relay Therapeutics, Inc.

CIK 0001812364

Entity typeother

Related Parties

1
  • filerCIK 0001816210

Filing Metadata

Form type
4
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:15 PM ET
Size
9.2 KB